Triple Agonist
Method: LC-MS
Reported result
NS-3 RTLab-reported verdict: Pass
Independent comparison: no comparable specification (not a failure)
From NorthStar Compounds · Lot RT402603
NorthStar Compounds
Reviewed against the original certificate. VialTalk reviewed the vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Credit is VialTalk's scoring credit, not a laboratory verdict; a test with no comparable specification is not a failed test. Scores above 100 reflect laboratory credibility weighting.
Method: LC-MS
Reported result
NS-3 RTLab-reported verdict: Pass
Independent comparison: no comparable specification (not a failure)
Method: HPLC
Reported result
99.42 %chromatographic areaLab-reported verdict: Pass
Independent comparison: Within the printed specification
≥99.25 %chromatographic area
Method: HPLC
Reported result
42.91 mgnot reportedLab-reported verdict: Pass
Independent comparison: no comparable specification (not a failure)
Method: PCR/DNA screening
Reported result
Not detectedLab-reported verdict: Pass
Independent comparison: no comparable specification (not a failure)
Method: USP <85> endotoxin
Reported result
0.105 EU/mgnot reportedLab-reported verdict: Pass
Independent comparison: no comparable specification (not a failure)
≤0.5 EU/mgPer vial
Only documented findings are shown. Additional testing is not established by this report. An omitted result is not a failing result.
Target